Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Diffuse Parenchymal Lung Disease
•
Primary Care
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
Answer from: at Academic Institution
For IPF patients and those on IS meds, every 4 months, I obtain Spirometry and DLCO. I obtain six-minute walk tests every 4-6 months.
Comments
at Medical Center Pulmonary Consultants
3-6 months.
13806
Sign in or Register to read more
25137
Related Questions
How do you approach the use of benzodiazepines in patients with chronic medical illnesses that may be susceptible to respiratory compromise (e.g., CHF, COPD, ILD)?
What is your approach to evaluation and management of GERD in a patient with IPF?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
What dose and duration of steroid therapy do you employ while starting mycophenolate in an outpatient with relatively stable CTD-ILD?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Would you initiate antifibrotic therapy in a patient with CTD-ILD experiencing worsening symptoms and declining lung function, despite no clear evidence of fibrosis on CT scans?
What is your approach to de-escalation of asthma inhaler therapy in the setting of negative bronchoprovocation testing when patients are averse to deprescribing?
Will you incorporate the use of tirzepatide in the management of patients with OSA?
Would you consider using steroids in patients with respiratory failure caused by aspiration pneumonitis?
What criteria do you use to decide when to perform a BAL in hypersensitivity pneumonitis?
3-6 months.